| Catalog Number |
PR60166930 |
| CAS |
60166-93-0 |
| Structure |  |
| Description |
Iopamidol is a Radiographic Contrast Agent. The mechanism of action of iopamidol is as a X-Ray Contrast Activity. |
| Synonyms |
Iopamiron; Iopamiro; Isovue; Niopam; Solutrast; iomapidol |
| IUPAC Name |
1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide |
| Molecular Weight |
777.1 |
| Molecular Formula |
C17H22I3N3O8 |
| InChI |
XQZXYNRDCRIARQ-LURJTMIESA-N |
| InChI Key |
InChI=1S/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h6-8,24-28H,2-5H2,1H3,(H,21,30)(H,22,31)(H,23,29)/t6-/m0/s1 |
| Drug Categories |
Acids, Carbocyclic; Benzene Derivatives; Benzoates; Compounds used in a research, industrial, or household setting; Contrast Media; Diagnostic Uses of Chemicals; Iodinated Contrast Agents; Iodobenzoates; Radiographic Contrast Agent; Roentgenography; Triiodobenzoic Acids; Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media; X-Ray Contrast Activity; X-Ray Contrast Media, Iodinated |
| Drug Interactions |
Aldesleukin-The risk of a hypersensitivity reaction to Iopamidol is increased when it is combined with Aldesleukin.
Metformin-The risk or severity of adverse effects can be increased when Iopamidol is combined with Metformin. |
| Isomeric SMILES |
C[C@@H](C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O |
| Standard |
USP |
| Type |
Small Molecule |
| Therapeutic Category |
Contrast Agent |
It should be noted that our service is only used for research, not for clinical use.
